Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
The U.S. Food and Drug Administration (FDA) is joining the cadre of government agencies calling attention to the cybersecurity risks of wireless, internet-and network-connected devices and…
From - G2 Compliance Advisor
The Department of Justice (DOJ) and the U.S. Department of Health and Human Services' Office of Inspector General (OIG) have been very active in fraud prevention and enforcement, recovering $3.3 billion in taxpayer dollars in…